Drug company Apotex Health Corp. is increasing the size of its initial public offering to about $1.3 billion, up from its earlier plan for $1 billion.
Drug company Apotex Health Corp. is increasing the size of its initial public offering to about $1.3 billion, up from its earlier plan for $1 billion.
The company says it now plans an offering of between 54.17 million and 65 million shares at a price per share between $20.00 and $24.00, compared with an earlier plan for 41.67 million and 50 million shares in the same price range.
Apotex, backers raise $1.3 billion in IPO priced at top
Apotex a revu à la hausse le prix de son introduction en bourse à 24 $ par action
Parabilis Medicines prices upsized IPO at $20 per share, raising $670 million above expected range
VolitionRx Announces Pricing of $4.6 Million Public Offering
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
Heart drug developer Kardigan seeks $1.4bn valuation in US IPO
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
Parabilis Medicines 33.5M share IPO priced at $20.00
Summit withdraws $500M offering, citing 'market conditions'
Parabilis sets a record with a $670M biotech IPO
TORONTO - Drug company Apotex Health Corp. says it is looking to sell about $1 billion worth of shares in its initial public…
Apotex Health Corp. filed for a Toronto Stock Exchange IPO that could raise up to C$1.2 billion, backed by C$3.5B in revenue and…
TORONTO - Apotex Health Corp. says it has filed a preliminary prospectus for an initial public offering that will see the…
Apotex Health Corp. raised $1.3 billion in a Toronto initial public offering, the country’s largest since 2021. Read more.
L’offre comprend une vente de 35 416 666 actions ordinaires nouvellement émises.
Canadian generic drugmaker Apotex Health Corp. filed for an initial public offering in Toronto. Find out more.
